About Us

icon_1_150px
Our Story

Combining the Best of Semiconductor Industry,
Nanoscience and Biotechnology

With the foresight to see the marriage of hi-tech with biotech to solve biological problems in a much more cost effective and time saving manner, Genvida was founded by the experts from the IC and nano-scale industries, and leaders in the high-throughput genomics sciences.

Genvida’s technologies and innovations are the fruits of the founding team-members’ 100+ years of combined working experience in science and engineering, and are covered by Genvida’s granted / pending patents in China, the European Union, Japan, Korea and the United States. The covered areas include sample preparation, micro-/nanofluidics architecture, solid-state nanopore fabrication, detector design, sequencing methods, system design, and bioinformatics. With this wide-ranging coverage, Genvida has created an environment that competitors cannot easily penetrate.

Milestones

  1. 2009
  2. 2016
  3. 2019
  4. 2020
  5. 2021
    • Applied the 1st US Patent for nanodevices technologies
    • Explored the in-situ nanopores etching method directly on silicon wafer
    • Initiated the idea for using nanochip in bioinformatics
    • Genvida was founded with the support of seeding Fund
    • Received the 1st batch of international patents for speeding-up the development of SONAS®  platform
    • Completed Series A angel investment
    • Received funding from the venture capital under Innovation and Technology Commission of HKSAR
    • Setup headquarter and laboratory in Hong Kong Science and Technology Parks
    • Designed and completed the installation of proprietary nanopore vacuum etching system
    • Completed the installation of picoampere monitoring system for nanochip
    • Signed strategic partnership agreement with research institutions in New York, Beijing and Hong Kong
    • Etched 50nm diameter nanopores on chip in our proprietary system
    • Completed the trademark registration of “SONAS” sequencing platform in USA and China
    • Achieved 10.8nm nanopores in the first half of the year
    • Nanopores size further reduced to 5nm in September
    • Received US patent of nano devcies using for DNA sequencing
    • Signed co-development agreement with reputable semiconductor company in Europe for wafer supply